Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Cash from Investing Activities (2018 - 2021)

Historic Cash from Investing Activities for Regen BioPharma (RGBP) over the last 5 years, with Q3 2021 value amounting to $195000.0.

  • Regen BioPharma's Cash from Investing Activities changed N/A to $195000.0 in Q3 2021 from the same period last year, while for Dec 2022 it was $495000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $25000.0 for FY2022, which is 9494.95% down from last year.
  • Regen BioPharma's Cash from Investing Activities amounted to $195000.0 in Q3 2021.
  • In the past 5 years, Regen BioPharma's Cash from Investing Activities ranged from a high of $300000.0 in Q2 2021 and a low of -$5741.0 during Q2 2018